Sun.Jan 28, 2024

article thumbnail

‘Food Equity Can’t Be a Side Gig’: How Food as Medicine is Becoming A Core Team Capability

MedCity News

As the food as medicine movement grows, some payers and healthcare organizations are carving out specific roles and teams dedicated to food and nutrition. Doing so can be beneficial considering the significant impact diet can have on health outcomes.

Food 132
article thumbnail

CHMP turns down Neuraxpharm, Apellis drugs

pharmaphorum

The CHMP has rejected marketing approvals for two drugs from Neuraxpharm and Apellis, but the pharma companies say they will appeal

Pharma 81
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma Just Increased the Price of Hundreds of Drugs. PBMs are Minimizing the Impact for Health Plans, Employers and Patients

MedCity News

While pharmaceutical companies continue to raise list prices year-over-year, we work behind the scenes to fight the trend by driving competition, negotiating with drugmakers and incentivizing the use of less expensive medicines that deliver the same clinical value.

article thumbnail

Alternative buffer management strategies to achieve downstream process improvements

PharmaTech

Buffers are used in great quantities when producing monoclonal antibodies (mAbs), and many biopharmaceutical companies — even large ones — do not have the processing capacity or infrastructure in-house to handle these large volumes. Whether it’s providing quality, pre-weighed, GMP-compliant raw materials or the entire buffer preparation step, there are options available to optimize your process.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Why Startups Are Seeking Out Health Systems’ VC Arms

MedCity News

Health system VC arms appear to have a lot more to offer to startups than traditional VC funds. Startup founders say that the tech pilots they launch with their health system partners end up being more effective because they are more incentive-aligned. For health systems, investing in a startup allows them to have a hand in shaping the tools they will eventually deploy across their enterprises to solve issues like burnout, payment delays and excessive hospital readmissions.

116
116
article thumbnail

Failing to plan is planning to fail: the case for early use of cGMP raw materials

PharmaTech

Knowing the right time to introduce cGMP raw materials when scaling up mAbs manufacturing avoids production process redevelopment, delays and increased costs. Using cGMP grade reagents earlier makes for a seamless transition while maintaining quality and viability. Learn key considerations for a seamless scale up process in our GMP fact sheet.

More Trending

article thumbnail

Ang Pow Awkwardness? Conquer CNY Gift-Giving with These Genius Tips

Contrarian Sales Techniques

Giving out festive gifts like those for Chinese New Year can be a very effective sales strategy, and here are some reasons why: Building relationships and goodwill: Demonstrates appreciation: A well-chosen gift shows your customers you value their business and are grateful for their support. This strengthens existing relationships and fosters positive feelings towards your brand.

article thumbnail

Building a Digital Stockpiling Strategy One Shelf At A Time

MedCity News

Shift from the stock shelf to the digital shelf and invest today in additive manufacturing technology so medical facilities can easily create repeatable, durable PPE on-demand printing to accelerate the process of securely printing equipment for medical professionals.

article thumbnail

Solving Cost and Supply Challenges in Biopharma Downstream Processing

PharmaTech

As the most expensive stage of monoclonal antibody production, downstream processing presents numerous opportunities to increase efficiency and raw material performance. This article discusses advances in purification process materials, as well as emerging technologies to aggregate and analyze data, as possible solutions to these challenges.

article thumbnail

New Web of Science Grants Index helps researchers develop more targeted grant proposals

Clarivate

Competition for funding is tough and researchers need help to make their grant applications stand out. The Web of Science Grants Index from Clarivate helps researchers seamlessly incorporate valuable awarded grant data from hundreds of funders into their grant proposal development. By exploring what has already been funded, researchers can make informed decisions when applying for new grants.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Particulate Matters: Categorizations, Considerations, and Compendia

PharmaTech

Webinar Date/Time: Wed, Mar 6, 2024 10:00 AM EST

52